Home World News FDA Grants Accelerated Approval to Dordaviprone for Diffuse Midline Glioma World News FDA Grants Accelerated Approval to Dordaviprone for Diffuse Midline Glioma By Ogkologos - August 22, 2025 747 0 Facebook Twitter Google+ Pinterest WhatsApp Evidence for efficacy is based on results from the ONC006, ONC013, ONC014, ONC016 and ONC018 studies Source RELATED ARTICLESMORE FROM AUTHOR Can ctDNA guide treatment intensification in EGFR mutated non-small cell lung cancer? How to select adjuvant endocrine therapy for postmenopausal women with HR-positive early breast cancer? EMA Recommends Extension of Therapeutic Indications for Abiraterone Acetate MOST POPULAR How My Navy Career Helped Shape My Positive Attitude During My... December 16, 2020 Many Men with Metastatic Prostate Cancer Are Not Getting the Recommended... February 18, 2025 Adding Retifanlimab To First-Line Chemotherapy for Patients with Advanced Squamous Cell... July 15, 2025 The Obesity Paradox: It Increases Diabetes Risk But Can Help Cancer... March 13, 2020 Load more HOT NEWS TG4001 Therapeutic Vaccination Plus Avelumab-Mediated PD-L1 Blockade Improves Tumour Microenvironment in... EMA Recommends Extension of Indications for Ponatinib Associated with a New... FDA Approves Pembrolizumab and Berahyaluronidase alfa-pmph for Subcutaneous Injection Beauty, Healing and Space
